The Future of Drug Development? Seeking Evidence of Activity of Novel Drugs in Small Groups of Patients
Author:
Affiliation:
1. Erasmus MC Cancer Institute, Erasmus MC, Rotterdam, the Netherlands
2. Mayo Clinic, Rochester, MN
Publisher
American Society of Clinical Oncology (ASCO)
Subject
Cancer Research,Oncology
Link
http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2013.48.7645
Reference13 articles.
1. Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas
2. Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial
3. Imatinib Mesylate in Advanced Dermatofibrosarcoma Protuberans: Pooled Analysis of Two Phase II Clinical Trials
4. Imatinib mesylate (STI-571 Glivec®, Gleevec™) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are unselected for a molecular target
5. Alveolar Soft Part Sarcoma: Clinical Presentation, Treatment, and Outcome in a Series of 33 Patients at a Single Institution
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Towards Precision Medicine in the Clinic: From Biomarker Discovery to Novel Therapeutics;Trends in Pharmacological Sciences;2017-01
2. Alveolar soft part sarcoma associated with lung and brain metastases: A case report;Oncology Letters;2016-06-15
3. Treatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine Trials;Journal of the National Cancer Institute;2015-11-23
4. Optimising translational oncology in clinical practice: Strategies to accelerate progress in drug development;Cancer Treatment Reviews;2015-02
5. Tumor genome analysis includes germline genome: Are we ready for surprises?;International Journal of Cancer;2014-08-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3